Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-061462
Filing Date
2025-03-24
Accepted
2025-03-24 17:20:36
Documents
5
Effectiveness Date
2025-03-24

Document Format Files

Seq Description Document Type Size
1 S-8 d930722ds8.htm S-8 39883
2 EX-5.1 d930722dex51.htm EX-5.1 7076
3 EX-23.1 d930722dex231.htm EX-23.1 1760
4 EX-FILING FEES d930722dexfilingfees.htm EX-FILING FEES 17006
5 GRAPHIC g930722g0318072304848.jpg GRAPHIC 2652
  Complete submission text file 0001193125-25-061462.txt   70757
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286062 | Film No.: 25765128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)